These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7449747)

  • 1. Modulation oestradiol effects by silver nitrate: inhibition of the adenohypophyseal reaction, block of the ceruloplasmin increase and block of hypothalamic ascorbic acid depletion.
    Schreiber V; Pribyl T; Jahodová J
    Endokrinologie; 1980 Oct; 76(2):129-36. PubMed ID: 7449747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactions of hypothalamic ascorbic acid, serum ceruloplasmin and the adenohypophysis to oestradiol: inhibition by L-thyroxine.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1980; 29(1):11-20. PubMed ID: 6444734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic modulation of the adenohypophyseal reaction to oestradiol: interaction of perphenazine with the thyroid hormones.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1980; 29(2):173-9. PubMed ID: 6446099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial inhibition of oestrogen-induced adenohypophyseal growth by silver nitrate.
    Pribyl T; Jahodová J; Schreiber V
    Horm Res; 1980; 12(5):296-303. PubMed ID: 7399401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between adenohypophyseal weight, serum polyphenol oxidase activity (ceruloplasmin) and hypothalamic ascorbic acid after estrogen treatment in rats.
    Schreiber V; Pribyl T; Jahodová J
    Horm Metab Res; 1980 Mar; 12(3):97-9. PubMed ID: 7372274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the oestradiol-induced increase in adenohypophyseal weight and in hypothalamic and serum polyphenol oxidase activity by dopaminergic agonists.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1983; 32(2):117-20. PubMed ID: 6408657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by an ergoline derivative (dopaminergic agonist) of oestradiol-induced adenohypophyseal growth and of the decrease in the hypothalamic ascorbic acid (HAA) concentration in rats.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1982; 31(2):97-100. PubMed ID: 6212960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dopamine-beta-hydroxylase inhibitor (disulfiram) on the response of adenohypophysis, serum ceruloplasmin and hypothalamic ascorbic acid to estradiol treatment.
    Schreiber V; Pribyl T; Jahodová J
    Endocrinol Exp; 1979 Sep; 13(3):131-8. PubMed ID: 315864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metoclopramide potentiates the hypophyseal reactions to oestradiol.
    Schreiber V; Dusková J; Pribyl T; Svobodová V; Jahodová J
    Physiol Bohemoslov; 1984; 33(5):385-9. PubMed ID: 6505072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the effect of oestradiol on adenohypophyseal weight: ineffectiveness of nickel chloride, potentiation by cimetidine.
    Schreiber V; Pribyl T; Svobodová V; Jahodová J
    Physiol Bohemoslov; 1984; 33(1):11-6. PubMed ID: 6709725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of hexose monophosphate shunt inhibitors on adenohypophyseal and ceruloplasmin reactions to oestrogen.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1978; 27(4):301-7. PubMed ID: 151286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of perphenazine and an ergoline derivative on oestrogen-induced adenohypophyseal growth.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; 26(1):31-8. PubMed ID: 140398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic antagonists potentiate the adenohypophyseal growth reaction to oestrogen: thioridazine is less effective than perphenazine.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1987; 36(1):9-13. PubMed ID: 2884683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioestrogenic action of the aldosterone antagonist canrenoate K in the rat (adenohypophysis, ceruloplasmin).
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; 26(5):385-95. PubMed ID: 144921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of interaction of oestrogen, testosterone and thyroid hormones on the serum ceruloplasmin level in rats.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; (2):129-37. PubMed ID: 140385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyphenol oxidase activity in the rat hypothalamus: stimulation after oestrogens and inhibition after the administration of silver.
    Pribyl T; Schreiber V; Jahodová J
    Physiol Bohemoslov; 1981; 30(6):525-30. PubMed ID: 6459594
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic control of adenohypophysial weight and serum ceruloplasmin level in rats.
    Schreiber V; Pribyl T
    Neuroendocrinology; 1976; 21(1):58-67. PubMed ID: 1004686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic control of adenohypophyseal growth.
    Schreiber V
    Vopr Biokhim Mozga; 1978; 13():221-7. PubMed ID: 756643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenohypophyseal and hypothalamic GABA B receptor subunits are downregulated by estradiol in adult female rats.
    Rey-Roldán EB; Bianchi MS; Bettler B; Becu-Villalobos D; Lux-Lantos VA; Libertun C
    Life Sci; 2006 Jun; 79(4):342-50. PubMed ID: 16516242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restitution of endocrine changes after discontinuing chronic oestradiol administration in rats.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1978; 27(6):505-13. PubMed ID: 152926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.